CT
Connecticut Senate Bill SB01011

Connecticut 2021 Regular Session

Connecticut Senate Bill SB01011 Compare Versions

OldNewDifferences
1+
2+
3+LCO 4402 \\PRDFS1\SCOUSERS\FORZANOF\WS\2021SB-01011-R02-
4+SB.docx
5+1 of 3
6+
7+General Assembly Raised Bill No. 1011
8+January Session, 2021
9+LCO No. 4402
10+
11+
12+Referred to Committee on PUBLIC SAFETY AND SECURITY
13+
14+
15+Introduced by:
16+(PS)
117
218
319
4-Senate Bill No. 1011
5-
6-Public Act No. 21-108
7-
8-
9-AN ACT CONCERNING THE USE OF OPIOID ANTAGONISTS BY
10-POLICE OFFICERS AND STUDYING THE USE OF EPINEPHRINE
11-CARTRIDGE INJECTORS BY POLICE OFFICERS.
20+AN ACT CONCERNING TH E USE OF OPIOID ANTAGONISTS AND
21+EPINEPHRINE CARTRIDG E INJECTORS BY POLICE OFFICERS.
1222 Be it enacted by the Senate and House of Representatives in General
1323 Assembly convened:
1424
15-Section 1. (NEW) (Effective from passage) (a) As used in this section, (1)
16-"law enforcement unit" and "police officer" have the same meanings as
17-provided in section 7-294a of the general statutes, and (2) "opioid
18-antagonist" has the same meaning as provided in section 17a-714a of the
19-general statutes.
20-(b) Each law enforcement unit shall (1) require its police officers to
21-receive training in the use of an opioid antagonist, and (2) acquire and
22-maintain a supply of opioid antagonists for use by its police officers
23-when responding to a medical emergency. Any police officer who
24-completes such training shall be permitted to carry and administer an
25-opioid antagonist to an individual whom the officer believes in good
26-faith is experiencing an opioid-related drug overdose.
27-Sec. 2. (Effective from passage) (a) As used in this section, (1)
28-"epinephrine cartridge injector" has the same meaning as provided in
29-section 19a-909 of the general statutes, and (2) "law enforcement unit"
30-and "police officer" have the same meanings as provided in section 7- Senate Bill No. 1011
25+Section 1. (NEW) (Effective from passage) (a) As used in this section, (1) 1
26+"epinephrine cartridge injector" has the same meaning as provided in 2
27+section 19a-909 of the general statutes; (2) "law enforcement unit" and 3
28+"police officer" have the same meanings as provided in section 7-294a of 4
29+the general statutes; and (3) "opioid antagonist" has the same meaning 5
30+as provided in section 17a-714a of the general statutes. 6
31+(b) Each law enforcement unit shall (1) require its police officers to 7
32+receive training in the use of an opioid antagonist and an epinephrine 8
33+cartridge injector, and (2) acquire and maintain a supply of opioid 9
34+antagonists and epinephrine cartridge injectors for use by its police 10
35+officers when responding to a medical emergency. 11
36+(c) Any police officer who completes such training shall be permitted 12
37+to carry and administer (1) an opioid antagonist to an individual whom 13
38+the officer believes in good faith is experiencing an opioid-related drug 14 Raised Bill No. 1011
3139
32-Public Act No. 21-108 2 of 3
3340
34-294a of the general statutes.
35-(b) The Police Officer Standards and Training Council, in
36-consultation with the Departments of Emergency Services and Public
37-Protection and Public Health, shall convene a working group to examine
38-and make recommendations regarding the feasibility of requiring police
39-officers to carry and administer an epinephrine cartridge injector to an
40-individual whom the officer believes in good faith is experiencing
41-anaphylaxis. At a minimum, the working group shall (1) determine if
42-the need for such requirement exists by examining data on the use of
43-epinephrine cartridge injectors by police officers and other first
44-responders and balancing the potential benefit to the public with the
45-potential impact to the police officer and law enforcement unit, (2)
46-address issues associated with such requirement, including the cost of
47-implementation and training police officers in the administration of
48-epinephrine cartridge injectors, (3) consult a medical expert regarding
49-the shelf life and safe storage practices of epinephrine cartridge
50-injectors, and (4) if the working group determines the need for such
51-requirement exists, make recommendations for legislation regarding
52-implementation.
53-(c) Not later than January 1, 2023, the council shall submit a report on
54-the findings and recommendations of the working group to the joint
55-standing committee of the General Assembly having cognizance of
56-matters relating to public safety and security, in accordance with the
57-provisions of section 11-4a of the general statutes. The working group
58-shall terminate on the date that the commissioner and council submit
59-such final report or January 1, 2023, whichever is later.
60- Senate Bill No. 1011
41+LCO 4402 {\\PRDFS1\SCOUSERS\FORZANOF\WS\2021SB-01011-
42+R02-SB.docx }
43+2 of 3
6144
62-Public Act No. 21-108 3 of 3
45+overdose, and (2) an epinephrine cartridge injector to an individual 15
46+whom the officer believes in good faith is experiencing anaphylaxis. 16
47+Sec. 2. Section 52-557v of the general statutes is repealed and the 17
48+following is substituted in lieu thereof (Effective from passage): 18
49+(a) A person (1) employed to work for the state or any political 19
50+subdivision thereof that has acquired and maintains a supply of 20
51+epinephrine cartridge injectors, (2) who is trained in the use of an 21
52+epinephrine cartridge injector in accordance with subdivision (2) of 22
53+subsection (a) of section 19a-909 or section 1 of this act, and (3) provides 23
54+or administers an epinephrine cartridge injector to an individual whom 24
55+the person believes in good faith is experiencing anaphylaxis during the 25
56+course of such person's employment, shall not be liable to such 26
57+individual for civil damages or subject to criminal prosecution for any 27
58+personal injuries that result from acts or omissions by such person in 28
59+using an epinephrine cartridge injector, which may constitute ordinary 29
60+negligence. The immunity provided in this subsection shall not apply to 30
61+wilful or wanton misconduct or acts or omissions constituting gross 31
62+negligence. 32
63+(b) The state or any political subdivision thereof that (1) has acquired 33
64+and maintains a supply of epinephrine cartridge injectors, and (2) 34
65+employs a person who (A) is trained in the use of an epinephrine 35
66+cartridge injector in accordance with subdivision (2) of subsection (a) of 36
67+section 19a-909 or section 1 of this act, and (B) provides or administers 37
68+an epinephrine cartridge injector to an individual whom the person 38
69+believes in good faith is experiencing anaphylaxis during the course of 39
70+such person's employment, shall not be liable to such individual for civil 40
71+damages for any personal injuries that result from acts or omissions by 41
72+such person in using an epinephrine cartridge injector, which may 42
73+constitute ordinary negligence. The immunity provided in this 43
74+subsection shall not apply to wilful or wanton misconduct or acts or 44
75+omissions constituting gross negligence. 45 Raised Bill No. 1011
6376
64-Certified as correct by
6577
66-_____________________________________________________________________
67-Legislative Commissioner.
68-_____________________________________________________________________
69-Clerk of the Senate.
70-_____________________________________________________________________
71-Clerk of the House.
72-Approved ________________________________________________, 2021
73-_____________________________________________________________________
74-Governor, State of Connecticut.
78+LCO 4402 {\\PRDFS1\SCOUSERS\FORZANOF\WS\2021SB-01011-
79+R02-SB.docx }
80+3 of 3
81+
82+This act shall take effect as follows and shall amend the following
83+sections:
84+
85+Section 1 from passage New section
86+Sec. 2 from passage 52-557v
87+
88+PS Joint Favorable
89+APP Joint Favorable
7590